These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29311047)

  • 21. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
    Hsu C; Tsou HH; Lin SJ; Wang MC; Yao M; Hwang WL; Kao WY; Chiu CF; Lin SF; Lin J; Chang CS; Tien HF; Liu TW; Chen PJ; Cheng AL;
    Hepatology; 2014 Jun; 59(6):2092-100. PubMed ID: 24002804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
    Miura K; Konishi J; Miyake T; Makita M; Hojo A; Masaki Y; Uno M; Ozaki J; Yoshida C; Niiya D; Kitazume K; Maeda Y; Takizawa J; Sakai R; Yano T; Yamamoto K; Sunami K; Hiramatsu Y; Aoyama K; Tsujimura H; Murakami J; Hatta Y; Kanno M
    Oncologist; 2017 May; 22(5):554-560. PubMed ID: 28408622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma.
    Morabad SS; Khan ZU; Gad R; Kallur N; Madhabhavi IV; Shalavadi MH; Mangannavar CV
    Indian J Pharmacol; 2023; 55(6):405-407. PubMed ID: 38174538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leucovorin-induced hypersensitivity reaction.
    Damaske A; Ma N; Williams R
    J Oncol Pharm Pract; 2012 Mar; 18(1):136-9. PubMed ID: 21248170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
    Kato H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sinusoidal obstruction syndrome induced by FOLFOX adjuvant chemotherapy].
    Chaput U; Coriat R; Terris B; Brezault C; Chaussade S
    Gastroenterol Clin Biol; 2008 Dec; 32(12):992-4. PubMed ID: 19019605
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vocal cord paralysis secondary to vincristine].
    Nafil H; Tazi I; Mahmal L
    Rev Neurol (Paris); 2012 May; 168(5):464-5. PubMed ID: 22387202
    [No Abstract]   [Full Text] [Related]  

  • 28. Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
    Choi YW; Jeong SH; Ahn MS; Lee HW; Kang SY; Choi JH; Jin UR; Park JS
    J Korean Med Sci; 2014 Nov; 29(11):1493-500. PubMed ID: 25408580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma.
    Lakshmaiah KC; Asati V; Babu K G; D L; Jacob LA; M C SB; K N L; L K R; A H R; Saldanha S; Koppaka D; Patidar R; C S P
    Eur J Haematol; 2018 Jun; 100(6):644-648. PubMed ID: 29569279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of neurotoxicity reduced with pregabalin in R-CHOP chemotherapy for diffuse large B-cell lymphoma].
    Nakashima T; Kiba T; Ogawa Y; Kimura A; Kido M; Okikawa Y; Ito T; Saito A; Hosokawa A; Shintani H; Okada Y; Taniguchi T; Taniyama K; Kozawa K; Niimi H
    Gan To Kagaku Ryoho; 2012 May; 39(5):809-12. PubMed ID: 22584337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M; Yamamoto G; Imai Y; Kurokawa M
    Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
    Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
    Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient adrenal insufficiency in diffuse large B cell lymphoma patients after chemotherapy with short-course, high-dose corticosteroids.
    Owattanapanich W; Sirinvaravong S; Suphadirekkul K; Wannachalee T
    Ann Hematol; 2018 Dec; 97(12):2403-2410. PubMed ID: 30109424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial.
    Vitolo U; Chiappella A; Franceschetti S; Carella AM; Baldi I; Inghirami G; Spina M; Pavone V; Ladetto M; Liberati AM; Molinari AL; Zinzani P; Salvi F; Fattori PP; Zaccaria A; Dreyling M; Botto B; Castellino A; Congiu A; Gaudiano M; Zanni M; Ciccone G; Gaidano G; Rossi G;
    Lancet Oncol; 2014 Jun; 15(7):730-7. PubMed ID: 24831981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent "flare" of dermatitis herpetiformis after cytotoxic therapy for malignant lymphoma.
    Gottlieb D; Commens C
    Med J Aust; 1986 Sep; 145(5):241. PubMed ID: 3528778
    [No Abstract]   [Full Text] [Related]  

  • 36. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
    Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
    Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma.
    Fisher RI
    Important Adv Oncol; 1990; ():217-25. PubMed ID: 2182520
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclophosphamide-induced generalised reticulated skin pigmentation: a rare presentation.
    Youssef M; Mokni S; Belhadjali H; Aouem K; Moussa A; Laatiri A; Zili J
    Int J Clin Pharm; 2013 Jun; 35(3):309-12. PubMed ID: 23468078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
    Vargo CA; Blazer M; Reardon J; Gulati M; Bekaii-Saab T
    Clin Colorectal Cancer; 2016 Jun; 15(2):e61-3. PubMed ID: 26701613
    [No Abstract]   [Full Text] [Related]  

  • 40. R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
    Hara T; Yoshikawa T; Goto H; Sawada M; Yamada T; Fukuno K; Kasahara S; Shibata Y; Matsumoto T; Mabuchi R; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Nannya Y; Katsumura N; Takahashi T; Kito Y; Takami T; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
    Hematol Oncol; 2018 Oct; 36(4):638-644. PubMed ID: 29882279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.